Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Safety, Tolerability and Pharmacokinetics Investigation of Stimotimagene Copolymerplasmid
Phase 1
Completed
- Conditions
- SarcomaMelanomaSquamous Cell Carcinoma of Head and NeckBreast NeoplasmsUterine Cervical NeoplasmsVulvar NeoplasmsPenile NeoplasmsAnus Neoplasms
- Interventions
- Biological: Stimotimagene copolymerplasmid
- First Posted Date
- 2022-10-13
- Last Posted Date
- 2024-07-01
- Lead Sponsor
- Gene Surgery LLC
- Target Recruit Count
- 21
- Registration Number
- NCT05578820
- Locations
- 🇷🇺
GBUZ Moscow Clinical Scientific Center named after Loginov MHD, Moscow, Russian Federation
🇷🇺FSBI N.N. Blokhin National Medical Research Center of Oncology of the Ministry of Health of Russia, Moscow, Russian Federation
🇷🇺FSBI National Medical Research Center for Obstetrics, Gynecology and Perinatology named after Academician V.I.Kulakov of the Ministry of Health of Russia, Moscow, Russian Federation
News
No news found